Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes

Hospitalization for major diabetes complications, including myocardial infarction, stroke, lower-extremity amputation, and end-stage kidney disease, is on the rise and represents a great health burden for patients with type 2 diabetes (T2D), in particular for older people. Newer glucose-lowering med...

Descripción completa

Detalles Bibliográficos
Autores principales: Giugliano, Dario, Longo, Miriam, Scappaticcio, Lorenzo, Caruso, Paola, Esposito, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798345/
https://www.ncbi.nlm.nih.gov/pubmed/33430860
http://dx.doi.org/10.1186/s12933-021-01213-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798345/
https://www.ncbi.nlm.nih.gov/pubmed/33430860
http://dx.doi.org/10.1186/s12933-021-01213-w

Ejemplares similares